Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells

Acta Histochemica

Volumn 114, Issue 2, 2012, Pages 151-158

  Yin, Zhenjie ^a   Zhang, Yan ^a   Li, Yu ^a   Lv, Tingting ^a   Liu, Jie ^a   Wang, Xinbo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; Immunohistochemistry; Non small cell lung cancer; Prognosis; RNA interference; STAT3

Indexed keywords

CASPASE 3; CISPLATIN; MESSENGER RNA; SMALL INTERFERING RNA; STAT3 PROTEIN;

AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CELL ASSAY; CHEMOSENSITIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MOLECULAR PATHOLOGY; ONCOGENE; OVERALL SURVIVAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; STAT3 GENE; SURVIVAL RATE; TUMOR DIFFERENTIATION; UPREGULATION;

AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84856453840     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.04.002     Document Type: Article

References (24)

1. Bonner J.A., Trummell H.Q., Willey C.D., Plants B.A., Raisch K.P. Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma. Radiother Oncol 2009, 92:339-344.
2. Chen C.L., Cen L., Kohout J., Hutzen B., Chan C., Hsieh F.C., et al. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer 2008, 7:78.
3. Coppo P., Gouilleux-Gruart V., Huang Y., Bouhlal H., Bouamar H., Bouchet S., et al. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma. Leukemia 2009, 23:1667-1678.
4. Ding B.B., Yu J.J., Yu R.Y., Mendez L.M., Shaknovich R., Zhang Y., et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 2008, 111:1515-1523.
5. Frank D.A. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007, 251:199-210.
6. Gao L.F., Xu D.Q., Wen L.J., Zhang X.Y., Shao Y.T., Zhao X.J. Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin 2005, 26:377-383.
7. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 2006, 56:106-130.
8. Kanda N., Seno H., Konda Y., Marusawa H., Kanai M., Nakajima T., et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004, 23:4921-4929.
9. Kim H.S., Park Y.H., Lee J., Ahn J.S., Kim J., Shim Y.M., et al. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray. Cancer 2010, 116:676-685.
10. Liu T., Peng H., Wu Z., Cui C. Expression and significance of signal transducer and activator of transcription 3 and c-myc in laryngeal squamous cell carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010, 4:648-651.
11. Liu T., Peng H., Zhang M., Deng Y., Wu Z., Cucurbitacin B. a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. Eur J Pharmacol 2010, 641:15-22.
12. Lee J., Kang W.K., Park J.O., Park S.H., Park Y.S., Lim H.Y., et al. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS 2009, 117:598-606.
13. Lee S.O., Lou W., Qureshi K.M., Mehraein-Ghomi F., Trump D.L., Gao A.C. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 2004, 60:303-309.
14. Min H., Wei-Hong Z. Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma. J Obstet Gynaecol Res 2009, 35:918-925.
15. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
16. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
17. Pectasides E., Egloff A.M., Sasaki C., Kountourakis P., Burtness B., Fountzilas G., et al. Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin Cancer Res 2010, 16:2427-2434.
18. Ryu K., Choy E., Yang C., Susa M., Hornicek F.J., Mankin H., et al. Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. J Orthop Res 2010, 28:971-978.
19. Takemoto S., Ushijima K., Kawano K., Yamaguchi T., Terada A., Fujiyoshi N., et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. Br J Cancer 2009, 101:967-972.
20. Yang G., Huang C., Cao J., Huang K.J., Jiang T., Qiu Z.J. Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion. World J Gastroenterol 2009, 15:3757-3766.
21. Yin Z.J., Jin F.G., Liu T.G., Fu E.Q., Xie Y.H., Sun R.L. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells. J Surg Res 2010 April.
22. Zhang X., Liu P., Zhang B., Wang A., Yang M. Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells. Cancer Genet Cytogenet 2010, 197:46-53.
23. Zhang X., Zhang J., Wang L., Wei H., Tian Z. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer 2007, 7:149.
24. Zhu B.R., Cai J.M., Tang G.S., Li B.L., Gao F., Cui J.G., et al. Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549. Ai Zheng 2007, 26:820-837.